These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4887080)

  • 1. Progress in leprosy.
    Bullock WE
    N Engl J Med; 1969 Apr; 280(16):896-7. PubMed ID: 4887080
    [No Abstract]   [Full Text] [Related]  

  • 2. Response in two groups of anergic patients to the transfer of leukocytes from sensitive donors.
    Rodriguez Paradisi E; De Bonaparte YP; Morgenfeld MC
    N Engl J Med; 1969 Apr; 280(16):859-61. PubMed ID: 4887076
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH; Rees RH; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the immunology of leprosy.
    Convit J; Ulrich M
    Int J Dermatol; 1976 Apr; 15(3):157-70. PubMed ID: 770348
    [No Abstract]   [Full Text] [Related]  

  • 5. [Leprosy as an immunological model].
    Godal T; Myrvang B; Samuel DR
    Tidsskr Nor Laegeforen; 1973 Feb; 93(4):217-22. PubMed ID: 4570661
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibodies against Mycobacterium leprae and their applications in leprosy research.
    Sengupta U; Sinha S
    Indian J Lepr; 1984; 56(4):727-41. PubMed ID: 6398337
    [No Abstract]   [Full Text] [Related]  

  • 7. An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy.
    Bullock WE; Fields JP; Brandriss MW
    N Engl J Med; 1972 Nov; 287(21):1053-9. PubMed ID: 4562439
    [No Abstract]   [Full Text] [Related]  

  • 8. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
    Laal S; Mishra RS; Nath I
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current thoughts on the immunology of leprosy].
    Sagaró Delgado B; Díaz de la Rocha Quevedo A; Díaz García MA; Martínez Granja R; Rodríguez García MA; Collazo Caballero S
    Rev Cubana Med Trop; 1988; 40(1):80-90. PubMed ID: 3045919
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.
    Myrvang B; Godal T; Ridley DS; Fröland SS; Song YK
    Clin Exp Immunol; 1973 Aug; 14(4):541-53. PubMed ID: 4583777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG.
    Rada EM; Convit J; Ulrich M; Gallinotto ME; Aranzazu N
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):646-50. PubMed ID: 2963084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lepra reactions.
    Godal T
    Ethiop Med J; 1973 Apr; 11(2):194-5. PubMed ID: 4596877
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological problems in leprosy research: 1.
    Lepr Rev; 1974 Sep; 45(3):244-72. PubMed ID: 4612274
    [No Abstract]   [Full Text] [Related]  

  • 14. Lepromin retesting as a factor of lepromin test positivation.
    Azulay RD
    Int J Lepr Other Mycobact Dis; 1974; 42(4):428-30. PubMed ID: 4617721
    [No Abstract]   [Full Text] [Related]  

  • 15. Microscopic findings of delayed reactions elicited by the skin test reagent Leprosin A derived from M. leprae.
    Samuel NM; Stanford JL; Desikan KV
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):395-403. PubMed ID: 3900246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative study of the relationship between systemic and histological parameters of immunity in individual leprosy patients.
    Cree IA; Smith WC; Beck JS
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):347-52. PubMed ID: 2198317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin.
    Fine PE; Gruer PJ; Maine N; Ponnighaus JM; Rees RJ; Stanford JL
    Clin Exp Immunol; 1989 Aug; 77(2):226-9. PubMed ID: 2673590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to mycobacterium leprae in man.
    Myrvang B
    J Oslo City Hosp; 1975 Jan; 25(1):3-24. PubMed ID: 1092818
    [No Abstract]   [Full Text] [Related]  

  • 19. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
    J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology and animal experimentation in leprosy.
    Shepard CC
    Cutis; 1976 Jul; 18(1):80-96. PubMed ID: 797549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.